Injective Surges 59% in 90 Days, Mimics Chainlink's 2024 Rally Pattern

Generated by AI AgentCoin World
Sunday, Jul 6, 2025 8:55 am ET1min read

As the third quarter of 2025 begins, the cryptocurrency market continues its upward trajectory from the second quarter, with

(ETH) leading the way, trading near $2,515 and showing a weekly gain of over 3%. This momentum has sparked interest in various altcoins, with (INJ) emerging as a standout performer. INJ has surged more than 59% in the past 90 days, but what has caught the attention of analysts is the fractal pattern it is currently forming, which bears a striking resemblance to the pattern seen in (LINK) before its significant rally in late 2024.

Looking back at LINK’s 2024 chart, it experienced a prolonged downtrend that culminated in a head-and-shoulders top formation, followed by a multi-month consolidation phase. The turning point came when LINK found strong support in a demand zone near $8.50 and reclaimed both its 50- and 100-week moving averages. This confluence of signals triggered a powerful rally, eventually sending LINK soaring to $30, marking a 200%+ gain.

Injective (INJ) appears to be following a nearly identical pattern. The price action recently tested INJ’s demand zone near $9, an area that previously acted as strong support, and has since bounced to a current price of $10.86. Similar to LINK’s past performance, INJ’s price is now compressing just below the 100-day moving average, which sits around $12.01. A decisive move above this level could signal a breakout for Injective, potentially flipping its momentum from bearish to bullish.

While technical setups do not guarantee outcomes, crypto markets have a strong tendency to repeat familiar fractals, especially when broader sentiment is turning positive. If Injective follows a similar recovery path to Chainlink, a breakout above $12.01 could mark the beginning of a significant uptrend. The next logical upside target for INJ sits near $18, representing a potential 66% gain from current levels.

Sign up for free to continue reading

Unlimited access to AInvest.com and the AInvest app
Follow and interact with analysts and investors
Receive subscriber-only content and newsletters

By continuing, I agree to the
Market Data Terms of Service and Privacy Statement

Already have an account?